Log in to save to my catalogue

Can ParC Ser83Ile status predict fluoroquinolone efficacy in Mycoplasma genitalium infection?

Can ParC Ser83Ile status predict fluoroquinolone efficacy in Mycoplasma genitalium infection?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2707616979

Can ParC Ser83Ile status predict fluoroquinolone efficacy in Mycoplasma genitalium infection?

About this item

Full title

Can ParC Ser83Ile status predict fluoroquinolone efficacy in Mycoplasma genitalium infection?

Publisher

London: Elsevier Ltd

Journal title

The Lancet infectious diseases, 2022-09, Vol.22 (9), p.1273-1274

Language

English

Formats

Publication information

Publisher

London: Elsevier Ltd

Subjects

More information

Alternative Titles

Full title

Can ParC Ser83Ile status predict fluoroquinolone efficacy in Mycoplasma genitalium infection?

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2707616979

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2707616979

Other Identifiers

ISSN

1473-3099

E-ISSN

1474-4457

DOI

10.1016/S1473-3099(22)00450-9

How to access this item